Anson Funds Management’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Anson Funds Management’s Portfolio MDGSW Stock Details MDGSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,400	Closed	-$5.91K	–	208
2023 Q1	$5.91K	Buy	+1,400	New	+$101	﹤0.01%	181
2022 Q4	–	Sell	-21,000	Closed	-$12K	–	282
2022 Q3	$12K	Hold	21,000	–	–	﹤0.01%	272
2022 Q2	$14K	Hold	21,000	–	–	﹤0.01%	319
2022 Q1	$23K	Hold	21,000	–	–	﹤0.01%	335
2021 Q4	$21K	Hold	21,000	–	–	﹤0.01%	338
2021 Q3	$33K	Hold	21,000	–	–	﹤0.01%	303
2021 Q2	$38K	Hold	21,000	–	–	﹤0.01%	282
2021 Q1	$47K	Hold	21,000	–	–	0.01%	247
2020 Q4	$40K	Hold	21,000	–	–	0.01%	168
2020 Q3	$29K	Hold	21,000	–	–	0.02%	87
2020 Q2	$36K	Hold	21,000	–	–	0.01%	67
2020 Q1	$21K	Hold	21,000	–	–	0.01%	57
2019 Q4	$37K	Hold	21,000	–	–	0.04%	79
2019 Q3	$36K	Buy	21,000 +5,375	+34%	+$2.59K	0.03%	33
2019 Q2	$39K	Sell	15,625 -5,375	-26%	-$2.6K	0.02%	38
2019 Q1	$62K	Hold	21,000	–	–	0.04%	29
2018 Q4	$55K	Buy	+21,000	New	+$14.3K	0.03%	51

Other funds holding MDGSW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Skaana Management Brooklyn, New York $465M AUM 58.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Anson Funds Management's MDGSW Position: Q2 2023 in Review

Anson Funds Management sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q2 2023, closing a stake of 1,400 shares — an estimated $5.91K sold.

Anson Funds Management first reported a position in MDGSW in Q4 2018 and held it in 17 quarters. The position peaked at $62K in Q1 2019. 5 funds tracked by Wall St. Rank hold MDGSW as of Q2 2023.

Anson Funds Management reported no remaining Medigus Ltd. Series C Warrant position as of Q2 2023 after selling out during the quarter.
Anson Funds Management sold 1,400 Medigus Ltd. Series C Warrant shares in Q2 2023, an estimated $5.91K.
Anson Funds Management first reported a position in Medigus Ltd. Series C Warrant in Q4 2018 and held it in 17 quarters.
Anson Funds Management's Medigus Ltd. Series C Warrant position peaked at $62K in Q1 2019.
5 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q2 2023.

Based on Anson Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.